Home > Insider Trading > Filing (0001628280-20-014895)

Filing Details

Accession Number:: 0001628280-20-014895
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-10-27 18:08:10
Reporting Period:: 2020-10-23

Accepted Time:: 2020-10-27 18:08:10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1576280	Guardant Health Inc.	GH	Services-Medical Laboratories (8071)	454139254

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1753159	Amirali Talasaz	505 Penobscot Drive Redwood City CA 94063	Chairman, President And Coo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-10-23	13,136	$105.15	701,264	No	4	S	Indirect	Shares held by Talasaz Investments, L.P.
Common Stock	Disposition	2020-10-26	4,613	$105.02	696,651	No	4	S	Indirect	Shares held by Talasaz Investments, L.P.
Common Stock	Disposition	2020-10-27	14,238	$105.35	682,413	No	4	S	Indirect	Shares held by Talasaz Investments, L.P.
Common Stock	Disposition	2020-10-27	25,263	$106.35	657,150	No	4	S	Indirect	Shares held by Talasaz Investments, L.P.
Common Stock	Disposition	2020-10-27	9,678	$107.44	647,472	No	4	S	Indirect	Shares held by Talasaz Investments, L.P.
Common Stock	Disposition	2020-10-27	13,272	$108.19	634,200	No	4	S	Indirect	Shares held by Talasaz Investments, L.P.
Common Stock	Disposition	2020-10-27	10,000	$109.28	624,200	No	4	S	Indirect	Shares held by Talasaz Investments, L.P.
Common Stock	Disposition	2020-10-27	3,400	$110.03	620,800	No	4	S	Indirect	Shares held by Talasaz Investments, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Shares held by Talasaz Investments, L.P.
No	4	S	Indirect	Shares held by Talasaz Investments, L.P.
No	4	S	Indirect	Shares held by Talasaz Investments, L.P.
No	4	S	Indirect	Shares held by Talasaz Investments, L.P.
No	4	S	Indirect	Shares held by Talasaz Investments, L.P.
No	4	S	Indirect	Shares held by Talasaz Investments, L.P.
No	4	S	Indirect	Shares held by Talasaz Investments, L.P.
No	4	S	Indirect	Shares held by Talasaz Investments, L.P.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,539,532	Direct

Footnotes

These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $105.00 to $105.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $105.00 to $105.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $105.00 to $105.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $106.00 to $106.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $107.00 to $107.995, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $108.00 to $108.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $109.00 to $109.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $110.00 to $110.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.